Institutional members access full text with Ovid®

Implants in facial skeletal augmentation

Brandt, Michael G.a; Moore, Corey C.b

Current Opinion in Otolaryngology & Head & Neck Surgery: August 2013 - Volume 21 - Issue 4 - p 396–399
doi: 10.1097/MOO.0b013e32836385d1
MAXILLOFACIAL SURGERY: Edited by Sherard A. Tatum

Purpose of review: Alloplastic implants have demonstrated longstanding utility in the augmentation of the facial skeleton. Although their popularity may have waned in recent years, their established efficacy endures. This review summarizes the techniques, limitations, and complications associated with the use of facial implants.

Recent findings: Given the recognized utility of facial implants in the augmentation of the facial skeleton, they have received little attention in the recent literature. Contemporary reports have focused on the refinement of techniques – with renewed interest in the vertical transoral approach, and expanding the scope of facial implants – that is, the utility of facial implants as alternatives and/or adjuncts to orthognathic surgery.

Summary: Facial augmentation using alloplastic implants remains a tried, tested, and true means of correcting skeletal insufficiencies and abnormalities. Thus, what was once old will be new again, and a renaissance in the use of facial implants will undoubtedly occur.

aDivision of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head and Neck Surgery, Faculty of Medicine, University of Toronto, Toronto

bDivision of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head and Neck Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

Correspondence to Dr Corey C. Moore, MD, MSc, FRCSC, Associate Professor, Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head and Neck Surgery, Schulich School of Medicine & Dentistry, University of Western Ontario, St. Joseph's Healthcare London, 268 Grosvenor Street, London, ON N6A 4V2, Canada. Tel: +1 519 646 6383; fax: +1 519 646 6173; e-mail: cmoore22@uwo.ca

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins